A new study reveals that the IRAK-M protein plays a crucial role in protecting retinal cell health, but its levels decrease with age, potentially due to increased oxidative stress. Researchers have found that gene therapy to boost IRAK-M expression can slow the progression of retinal damage in mice models. This promising approach holds potential for treating age-related macular degeneration (AMD), a condition affecting millions worldwide and causing vision impairment. Addressing IRAK-M levels could be a key strategy in combating AMD and preserving retinal function. Find out more about this groundbreaking research at the link provided.
Link: https://www.bristol.ac.uk/news/2024/june/amd-study.html
